omr-igg-am
Biologicalexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2003 (NCT00068055)
Timeline
Indications
Studied for
Mechanism of action
- West Nile virusImmunity, passive
West Nile virus immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- omr-igg-am
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00069316 | Phase 2 | Sep 22, 2003 | National Institutes of Health (NIH) |
| NCT00068055 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2003 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2003 |
| National Institutes of Health (NIH) | Government | 1 | 1 | 1 | 2003 |
2 organizations
Page 1 / 1